A vs ALT: Which Stock is Better?
Side-by-side comparison of Agilent Technologies Inc and Altimmune Inc in 2026
A
Agilent Technologies Inc
$118.25
ALT
Altimmune Inc
$3.40
Key Metrics Comparison
| Metric | A | ALT | Winner |
|---|---|---|---|
| Market Cap | $33.88B | $428.05M | A |
| P/E Ratio | 26.62 | N/A | A |
| EPS (TTM) | $4.50 | $N/A | A |
| Revenue Growth | 0.1% | 4.2% | ALT |
| Gross Margin | 52.3% | -161929.3% | A |
Analyze A
Full quant analysis
Analyze ALT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is A or ALT a better investment?
Comparing A and ALT: Agilent Technologies Inc has a market cap of $33.88B while Altimmune Inc has $428.05M. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between A and ALT?
A (Agilent Technologies Inc) and ALT (Altimmune Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: A or ALT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: A or ALT?
ALT has higher revenue growth at 4.2% vs 0.1% for A.
Which company is more profitable: A or ALT?
Agilent Technologies Inc (A) has higher gross margins at 52.3% compared to -161929.3% for ALT.
Which is the larger company: A or ALT?
Agilent Technologies Inc (A) is larger with a market cap of $33.88B compared to $428.05M for ALT.
Should I buy A or ALT in 2026?
Both A and ALT have investment merit. A trades at $118.25 while ALT trades at $3.40. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between A and ALT stock?
Key differences: Market Cap ($33.88B vs $428.05M), P/E Ratio (26.6x vs N/A), Revenue Growth (0.1% vs 4.2%), Gross Margin (52.3% vs -161929.3%).